{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:26:42Z","timestamp":1789140402274,"version":"build-2803163510"},"reference-count":100,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Liver Journal"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p> Approximately 25% of people in Canadian correctional facilities have been previously exposed to hepatitis C virus (HCV). Despite being a high-prevalence setting, most Canadian prisons have thus far failed to engage the majority of those with chronic HCV infection in care. Several factors, including the lack of systematic screening programs, lack of on-site and trained health care personnel to improve access to care and treatment during incarceration, and the absence of standardized procedures needed to facilitate linkage to care following release likely contribute to poor engagement along the HCV care cascade for people in prison. HCV screening and engagement in care for people in prison can be improved through the implementation of universal opt-out screening upon admission and consideration of multidisciplinary care models for the provision of care. As well, the dissemination of prison-based needle and syringe programs to avert new HCV infections and re-infections should be considered. To meet the World Health Organization (WHO) 2030 HCV elimination goals, engaging researchers, clinicians and other health care providers, policy makers, correctional officials, and members of community in dialogue will be an essential first step going forward. <\/jats:p>","DOI":"10.3138\/canlivj.2019-0007","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T14:29:10Z","timestamp":1560349750000},"page":"171-183","source":"Crossref","is-referenced-by-count":32,"title":["Hepatitis C virus (HCV) care in Canadian correctional facilities: Where\u00a0are we and where do we need to be?"],"prefix":"10.3138","volume":"2","author":[{"given":"Nadine","family":"Kronfli","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A","family":"Buxton","sequence":"additional","affiliation":[{"name":"BC Centre of Disease Control and School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Jennings","sequence":"additional","affiliation":[{"name":"Prisoners with HIV\/AIDS Support Action Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Kouyoumdjian","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Centre for Urban Health Solutions, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Saskatchewan, Regina, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"key":"r1","unstructured":"1.World Health Organization. Combating hepatitis B and C to reach elimination by 2030. Advocacy Brief. Geneva: WHO; 2016. http:\/\/www.who.int\/hepatitis\/publications\/hep-elimination-by-2030-brief\/en\/ (Accessed December 18, 2018)."},{"issue":"4","key":"r2","doi-asserted-by":"crossref","first-page":"E605","DOI":"10.9778\/cmajo.20160008","volume":"4","author":"Marshall AD","year":"2016","journal-title":"CMAJ Open"},{"issue":"3","key":"r3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2055-6640(20)30329-0","volume":"3","author":"Hill AM","year":"2017","journal-title":"J Virus Erad"},{"key":"r4","unstructured":"4.World Health Organization. Prisons and health. Enggist S, Moller L, Galea G, Udesen\u00a0C, eds. Copenhagen: WHO; 2014. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0005\/249188\/Prisons-and-Health.pdf (Accessed December 18, 2018)."},{"key":"#cr-split#-r5.1","unstructured":"5.Reitano J. Adult correctional statistics in Canada, 2015\/2016 [Internet]. Catalogue no. 85-002-X. Ottawa: Canadian Centre for Justice Statistics. Statistics Canada"},{"key":"#cr-split#-r5.2","unstructured":"2017. http:\/\/www.statcan.gc.ca\/pub\/85-002-x\/2017001\/article\/14700-eng.pdf (Accessed December\u00a018, 2018)."},{"key":"r6","unstructured":"6.Correctional Service Canada. Facilities & securities [Internet]. Ottawa: Correctional Service Canada; c2018 [updated 2018 Nov 7]. http:\/\/www.csc-scc.gc.ca\/facilities-and-security\/index-eng.shtml (Accessed December 18, 2018)."},{"key":"r7","unstructured":"7.World Prison Brief. World prison brief data \u2013 North America, Canada, overview. London, UK: Birkbeck University of London; 2018. http:\/\/www.prisonstudies.org\/country\/canada (Accessed January 7, 2018)."},{"key":"r8","doi-asserted-by":"crossref","unstructured":"8.Trubnikov M, Yan P, Archibald C. Estimated prevalence of hepatitis C virus infection in Canada, 2011. CCDR: Volume 40-19, December\u00a018, 2014. Ottawa: Public Health Agency of Canada; 2014. http:\/\/www. phacaspc.gc.ca\/publicat\/ccdr-rmtc\/14vol40\/dr-rm40-19\/surveillance-b-eng.php (Accessed December\u00a018, 2018).","DOI":"10.14745\/ccdr.v40i19a02"},{"key":"r9","unstructured":"9.Challacombe L. The epidemiology of hepatitis C in Canada [Internet]. Toronto: CATIE; 2017. http:\/\/www.catie.ca\/en\/fact-sheets\/epidemiology\/epidemiology-hepatitis-c-canada (Accessed December 18, 2018)."},{"issue":"2","key":"r10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF03405520","volume":"100","author":"Buxton JA","year":"2009","journal-title":"Can J Public Health"},{"key":"r11","unstructured":"11.Farrell S, Ross J, Ternes M, Kunic D. Prevalence of injection drug use among male offenders. Ottawa: Correctional Service Canada; 2010. http:\/\/www.csc-scc.gc.ca\/research\/005008-rs10-02-eng.shtml (Accessed December 18, 2018)."},{"issue":"4","key":"r12","first-page":"297","volume":"98","author":"Gagnon H","year":"2007","journal-title":"Can\u00a0J Public Health"},{"issue":"3","key":"r13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1503\/cmaj.060760","volume":"177","author":"Poulin C","year":"2007","journal-title":"CMAJ"},{"key":"#cr-split#-r14.1","unstructured":"14.Thompson J, Zakaria D, Grant B. Aboriginal men: a summary of the findings of the 2007 National Inmate Infectious Diseases and Risk-Behaviours Survey. Research report R-237. Ottawa: Correctional Service Canada"},{"key":"#cr-split#-r14.2","unstructured":"2011. http:\/\/www.csc-scc.gc.ca\/research\/005008-0237-eng.shtml (Accessed December 18, 2018)."},{"issue":"32","key":"r15","doi-asserted-by":"crossref","first-page":"E1052","DOI":"10.1503\/cmaj.1095468","volume":"189","author":"Webster P","year":"2017","journal-title":"CMAJ"},{"issue":"4","key":"r16","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1503\/cmaj.171142","volume":"190","author":"Kronfli N","year":"2018","journal-title":"CMAJ"},{"issue":"11","key":"r17","doi-asserted-by":"crossref","first-page":"e25197","DOI":"10.1002\/jia2.25197","volume":"21","author":"Kronfli N","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"10050","key":"r18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(16)30856-X","volume":"388","author":"Altice FL","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"r19","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/add.13783","volume":"112","author":"Stone J","year":"2017","journal-title":"Addiction"},{"issue":"12","key":"r20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","volume":"18","author":"Stone J","year":"2018","journal-title":"Lancet ID"},{"issue":"2","key":"r21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/M15-0617","volume":"164","author":"He T","year":"2016","journal-title":"Ann Intern Med"},{"key":"r22","unstructured":"22.World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Geneva: WHO; 2016. https:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/ (Accessed December 10, 2018)."},{"issue":"16","key":"r23","doi-asserted-by":"crossref","first-page":"E594","DOI":"10.1503\/cmaj.161521","volume":"189","author":"Grad R","year":"2017","journal-title":"CMAJ"},{"issue":"22","key":"r24","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1503\/cmaj.170453","volume":"190","author":"Shah H","year":"2018","journal-title":"CMAJ"},{"key":"r25","unstructured":"25.World Health Organization. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection Geneva: WHO; 2016 [updated April 2016]. https:\/\/www.who.int\/hepatitis\/publications\/hepatitis-c-guidelines-2016\/en\/ (Accessed December 8, 2018)."},{"key":"r26","unstructured":"26.Courtemanche Y, Poulin C, Serhir B, Alary M. \u00c9tude de pr\u00e9valence du VIH et du VHC chez les personnes incarc\u00e9r\u00e9es dans les \u00e9tablissements de d\u00e9tention provinciaux au Qu\u00e9bec. Qu\u00e9bec, QC: Institut national de sant\u00e9 publique du Qu\u00e9bec; 2016. French. https:\/\/www.inspq.qc.ca\/sites\/default\/files\/documents\/itss\/rapport_vih_vhc_milieu_carceral.pdf (Accessed December 12, 2018)."},{"issue":"11","key":"r27","doi-asserted-by":"crossref","first-page":"e7648","DOI":"10.1371\/journal.pone.0007648","volume":"4","author":"Kavasery R","year":"2009","journal-title":"PLoS One"},{"issue":"11","key":"r28","doi-asserted-by":"crossref","first-page":"e8056","DOI":"10.1371\/journal.pone.0008056","volume":"4","author":"Kavasery R","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"r29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.idc.2018.02.014","volume":"32","author":"Spaulding AC","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"r30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2018.04.003","volume":"57","author":"Kronfli N","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"6","key":"r31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1753-6405.12578","volume":"40","author":"Winter RJ","year":"2016","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"r32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/pubmed\/fdv023","volume":"38","author":"Beckwith CG","year":"2016","journal-title":"J Public Health (Oxf)"},{"issue":"4","key":"r33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2893.2007.00937.x","volume":"15","author":"Hickman M","year":"2008","journal-title":"J Viral Hepat"},{"issue":"2","key":"r34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/eurpub\/cku096","volume":"25","author":"Craine N","year":"2015","journal-title":"Eur J Public Health"},{"issue":"12","key":"r35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jech-2014-204451","volume":"68","author":"McLeod A","year":"2014","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"r36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jvh.13017","volume":"26","author":"Morey S","year":"2019","journal-title":"J Viral Hepat"},{"issue":"12","key":"r37","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/infdis\/jiy114","volume":"217","author":"Lamoury FM","year":"2018","journal-title":"J Infect Dis"},{"key":"r38","unstructured":"38.Canadian AIDS Treatment Information Exchange (CATIE). New point of care hepatitis C antibody test approved in Canada. Toronto: CATIE; 2017. https:\/\/www.catie.ca\/en\/catienews\/2017-02-08\/new-point-care-hepatitis-c-antibody-test-approved-canada (Accessed December 12, 2018)."},{"issue":"2","key":"r39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11524-015-9945-4","volume":"92","author":"Kuncio DE","year":"2015","journal-title":"J Urban Health"},{"issue":"8","key":"r40","doi-asserted-by":"crossref","first-page":"e003153","DOI":"10.1136\/bmjopen-2013-003153","volume":"3","author":"Martin NK","year":"2013","journal-title":"BMJ Open"},{"issue":"6","key":"r41","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/hep.28497","volume":"63","author":"Martin NK","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"r42","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jvh.12580","volume":"23","author":"Aspinall EJ","year":"2016","journal-title":"J Viral Hepat"},{"key":"r43","unstructured":"43.Pan-Canadian Pharmaceutical Alliance. A statement from the pan-Canadian Pharmac-eutical Alliance. Press release, February\u00a021, 2017. Toronto: CNW Group Ltd. 2017. https:\/\/www.newswire.ca\/news-releases\/a-statement-from-the-pan-canadian-pharmaceutical-alliance- 614373463.html (Accessed December\u00a012, 2018)."},{"issue":"2","key":"r44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"Binswanger IA","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"r45","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/add.13803","volume":"112","author":"Bukten A","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"r46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2010.11.029","volume":"117","author":"Binswanger IA","year":"2011","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"r47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/ofid\/ofx142","volume":"4","author":"MacDonald R","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"r48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40352-017-0055-0","volume":"5","author":"Hochstatter KR","year":"2017","journal-title":"Health Justice"},{"issue":"2","key":"r49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/00333549161310S215","volume":"131","author":"Schoenbachler BT","year":"2016","journal-title":"Public Health Rep"},{"issue":"5","key":"r50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/cid\/cir446","volume":"53","author":"Springer SA","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"r51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2105\/AJPH.2017.304250","volume":"108","author":"Myers JJ","year":"2018","journal-title":"Am J Public Health"},{"issue":"3","key":"r52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1108\/IJPH-08-2016-0037","volume":"13","author":"Myers JJ","year":"2017","journal-title":"Int J Prison Health"},{"issue":"2","key":"r53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/apc.2013.0279","volume":"28","author":"Koester KA","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"r54","unstructured":"54.Centers for Disease Control and Prevention. Effective interventions: HIV navigation services [Internet]. Atlanta: CDC; c2017 [updated 2018; cited 2018 Dec 18] https:\/\/effectiveinterventions.cdc.gov\/en\/care-medication-adherence\/group-2\/hiv-navigation-services."},{"key":"r55","unstructured":"55.Canadian AIDS Treatment Information Exchange (CATIE). Practice guidelines for peer health navigation for people living with HIV. Toronto: CATIE; 2018. http:\/\/www.catie.ca\/sites\/default\/files\/practice-guidelines-peer-nav-en-02082018.pdf (Accessed December 12, 2018)."},{"key":"r56","unstructured":"56.Akiyama M. Implementation and evaluation of a care coordination program for patients with hepatitis C following release from jail. Abstract number: 1010. AASLD Liver Meeting; 2017; San Francisco, CA, USA."},{"key":"r57","unstructured":"57.Fridriksdottir RH et\u00a0al. \u201cMarked reduction of hepatitis C prevalence in the prison setting during 2nd year of TraP HepC (Treatment as Prevention for Hepatitis C) program in Iceland.\u201d INHSU 2018, Lisbon, Portugal."},{"issue":"3","key":"r58","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cid\/ciy210","volume":"67","author":"Bartlett SR","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"r59","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","volume":"113","author":"Cuadrado A","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"27","key":"r60","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","volume":"373","author":"Feld JJ","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"r61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2017.03.039","volume":"67","author":"Kwo PY","year":"2017","journal-title":"J Hepatol"},{"key":"r62","unstructured":"62.Minist\u00e8re de la Sant\u00e9 et des Services sociaux. La prise en charge et le traitement des personnes infect\u00e9es par le virus de l\u2019h\u00e9patite C \u2013 Guide pour les professionnels de la sant\u00e9 du Qu\u00e9bec. February 2018. 85p. French. http:\/\/publications.msss.gouv.qc.ca\/msss\/fichiers\/2017\/17-267-01W.pdf (Accessed December 12, 2018)."},{"issue":"12","key":"r63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.7326\/M15-0642","volume":"163","author":"Kohli A","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9973","key":"r64","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(14)61228-9","volume":"385","author":"Kohli A","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"r65","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1016\/S0168-8278(15)30013-1","volume":"62","author":"Poordad F","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"r66","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/liv.13335","volume":"37","author":"Sulkowski MS","year":"2017","journal-title":"Liver Int"},{"issue":"4","key":"r67","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/cid\/civ897","volume":"62","author":"Kattakuzhy S","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"r68","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/j.gastro.2016.05.021","volume":"151","author":"Gane EJ","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"r69","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/M17-0118","volume":"167","author":"Kattakuzhy S","year":"2017","journal-title":"Ann Intern Med"},{"issue":"8","key":"r70","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/cid\/cis1202","volume":"56","author":"Lloyd AR","year":"2013","journal-title":"Clin Infect Dis"},{"key":"r71","unstructured":"71.Kirby Institute. Surveillance and treatment of prisoners with hepatitis C (SToP-C)[Internet]. Kensington, NSW: Kirby Institute; c2018. https:\/\/kirby.unsw.edu.au\/project\/stop-c (Accessed December 18, 2018)."},{"issue":"2","key":"r72","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1093\/cid\/cit265","volume":"57","author":"Post JJ","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"r73","doi-asserted-by":"crossref","first-page":"874","DOI":"10.5604\/01.3001.0010.5277","volume":"16","author":"Cooper CL","year":"2017","journal-title":"Ann Hepatol"},{"key":"r74","unstructured":"74.Llerena S et\u00a0al. Poster presentation AASLD 2018: Efficiency of a Telemedicine Program in the Management of Hepatitis C in Inmates. Hepatology, Oct. 36A."},{"issue":"23","key":"r75","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","volume":"364","author":"Arora S","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"r76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1360-0443.2008.02387.x","volume":"104","author":"DeBeck K","year":"2009","journal-title":"Addiction"},{"issue":"1","key":"r77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1108\/IJPH-09-2014-0032","volume":"11","author":"Wright NM","year":"2015","journal-title":"Int J Prison Health"},{"key":"r78","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.drugalcdep.2017.10.030","volume":"183","author":"Lafferty L","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"r79","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/10826084.2016.1264974","volume":"52","author":"Van der Meulen E","year":"2017","journal-title":"Subst Use Misuse"},{"issue":"9","key":"r80","doi-asserted-by":"crossref","first-page":"e0162399","DOI":"10.1371\/journal.pone.0162399","volume":"11","author":"Treloar C","year":"2016","journal-title":"PloS One."},{"key":"r81","unstructured":"81.World Health Organization (WHO). Declaration on prison health as part of public health. Moscow. Geneva: WHO; 2003 Oct 24. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0007\/98971\/E94242.pdf (Accessed December 12, 2018)."},{"issue":"9","key":"r82","first-page":"CD012021","author":"Platt L","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"r83","unstructured":"83.Van der Meulen E, Claivaz-Loranger C, Clarke S, Ollner A, Watson TM. On point: recommendations for prison-based needle and syringe programs in Canada. Toronto: Canadian HIV\/AIDS Legal Network; 2016. http:\/\/www.aidslaw.ca\/site\/download\/13446\/ (Accessed December 12, 2018)."},{"key":"r84","unstructured":"84.Public Health Agency of Canada. The effectiveness of bleach in the prevention of hepatitis C transmission. Final Report. Ottawa: Public Health Agency of Canada; 2004. http:\/\/publications.gc.ca\/collections\/Collection\/H39-4-37-2004E.pdf (Accessed January 7, 2019)."},{"key":"r85","unstructured":"85.United Nations Office on Drugs and Crime (UNODC). A handbook for starting and managing needle and syringe programmes in prisons and other closed settings. Advance copy. Vienna: UNODC; 2014. https:\/\/www.unodc.org\/documents\/hiv-aids\/publications\/Prisons_and_other_closed_settings\/ADV_COPY_NSP_PRISON_AUG_2014.pdf (Accessed December 12, 2018)."},{"issue":"5","key":"r86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.drugpo.2003.08.001","volume":"14","author":"St\u00f6ver H","year":"2003","journal-title":"Int J Drug Policy"},{"key":"r87","unstructured":"87.Canadian HIV\/AIDS Legal Network. Canada can\u2019t wait: the time for prison-based needle and syringe programs is now. Toronto: Canadian HIV\/AIDS Legal Network; 2016. http:\/\/www.aidslaw.ca\/site\/canada-cant-wait\/?lang=en (Accessed December 12, 2018)."},{"key":"r88","unstructured":"88.Correctional Service Canada. Backgrounder: Correctional Service Canada Prison Needle Exchange Program. Ottawa: Government of Canada; 2018. https:\/\/www.canada.ca\/en\/correctional-service\/news\/2018\/05\/backgrounder-correctional-service-canada-prison-needle-exchange-program.html#shr-pg0 (Accessed December 12, 2018)."},{"issue":"2","key":"r89","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09687637.2016.1148117","volume":"23","author":"St\u00f6ver H","year":"2016","journal-title":"Drugs Educ Prev Policy"},{"issue":"2","key":"r90","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","volume":"65","author":"Fullerton CA","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"2","key":"r91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","volume":"23","author":"Connery HS","year":"2015","journal-title":"Harv Rev Psychiatry"},{"issue":"10","key":"r92","first-page":"1154","volume":"167","author":"Sibbald B","year":"2002","journal-title":"CMAJ"},{"key":"r93","unstructured":"93.Canadian Centre on Substance Use and Addiction (CCSA). Supporting reintegration in Corrections by addressing problematic substance use: an environmental scan. Ottawa: CCSA; 2017. https:\/\/www.ccsa.ca\/sites\/default\/files\/2019-04\/CCSA-Reintegration-Corrections-Problematic-Substance-Use-Environmental-Scan-2017-en.pdf (Accessed March 11, 2019)."},{"key":"r94","unstructured":"94.Correctional Service Canada. Institutional methadone maintenance treatment: impact on release outcome and institutional behaviour. Ottawa: Correctional Service Canada; 2001. https:\/\/www.csc-scc.gc.ca\/research\/r119-eng.shtml (Accessed March 11, 2019)."},{"key":"r95","unstructured":"95.Correctional Service Canada. Use of bleach and the methadone maintenance treatment program as harm reduction measures in Canadian penitentiaries. Ottawa: Correctional Service Canada; 2010. http:\/\/www.csc-scc.gc.ca\/recherche\/005008-0210-01-eng.shtml (Accessed March 11, 2019)."},{"issue":"7","key":"r96","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0706743717711167","volume":"62","author":"Eibl JK","year":"2017","journal-title":"Can J Psychiatry"},{"issue":"11","key":"r97","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1016\/j.ijid.2010.03.019","volume":"14","author":"Jafari S","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"3","key":"r98","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1503\/cmaj.070854","volume":"177","author":"Elliott R","year":"2007","journal-title":"CMAJ"}],"container-title":["Canadian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/canlivj.2019-0007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:25:40Z","timestamp":1741872340000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/canlivj.2019-0007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.3138\/canlivj.2019-0007"],"URL":"https:\/\/doi.org\/10.3138\/canlivj.2019-0007","relation":{},"ISSN":["2561-4444","2561-4444"],"issn-type":[{"value":"2561-4444","type":"print"},{"value":"2561-4444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}